Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer, January 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 230 articles:
HTML format


 

Single Articles

  1. SHI A, Yerebake M, Du Z, Li L, et al
    Acupuncture as adjunctive therapy for cervical cancer pain: a systematic review and meta-analysis.
    J Pain Symptom Manage. 2025 Dec 31:S0885-3924(25)01021.
    PubMed    
    Abstract available

  2. PANT S
    ACS: New Cervical Cancer Screening Guidelines.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23004.
    PubMed    


  3. WANG F, Wang L, Bai Y
    Research progress of ferroptosis in cervical cancer treatment.
    Ann Med. 2026;58:2611208.
    PubMed    
    Abstract available

  4. ZHANG J, Fu C, Du J
    Artificial intelligence-assisted noninvasive preoperative prediction of lymph nodes metastasis in cervical cancer through a clinical-imaging feature combined strategy.
    Front Oncol. 2025;15:1669396.
    PubMed    
    Abstract available

  5. BUSTOS-GUTIERREZ MT, Morales-Casetti ML, Vasquez-Palma OA, Bustos-Gutierrez LR, et al
    [Social determinants of health that influence pap smear and mammography screening in Chilean women].
    Rev Salud Publica (Bogota). 2025;27:114162.
    PubMed    
    Abstract available

  6. HIRAKAWA A, Iwai N, Yanai A, Matsukawa K, et al
    Efficacy of Sentinel Lymph Node Sampling for Early Cervical Cancer: A Single Institute Study.
    J Obstet Gynaecol Res. 2026;52:e70144.
    PubMed    
    Abstract available

  7. TANG C, Jin X
    Deubiquitinating enzymes in endometrial cancer and cervical cancer.
    Gene. 2025 Dec 30:149988. doi: 10.1016/j.gene.2025.149988.
    PubMed    
    Abstract available

  8. LIU T, Zhang L, Li Y, Liao W, et al
    Glutamine metabolites promote the progression of cervical cancer by inducing M2 macrophage polarization.
    Pathol Res Pract. 2025;278:156348.
    PubMed    
    Abstract available

  9. RAJI PS, Thomas A, Thomas DS, Thomas V, et al
    Compliance to Standards of Colposcopy in an Effort to Reduce the Cervical Cancer Burden: An Audit.
    J Obstet Gynaecol India. 2025;75:461-466.
    PubMed    
    Abstract available

  10. ASFAW MS, Kassahun W
    The role of microRNAs on autophagy in cervical cancer: review.
    Discov Oncol. 2025 Dec 31. doi: 10.1007/s12672-025-04284.
    PubMed    


  11. PINGAULT O, Moskal A, Bouvard C, Payet C, et al
    Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study.
    BMJ Open. 2025;15:e108897.
    PubMed    
    Abstract available

  12. ASARE M, Ebu Enyan NI, Sencherey VL, Lamptey-Mills E, et al
    Culturally adapting and evaluating an evidence-based communication intervention with HPV self-sampling to improve cervical cancer screening among women living with HIV in Ghana: a mixed-methods study.
    BMJ Open. 2025;15:e105852.
    PubMed    
    Abstract available

  13. LU X, Feng L, Zhang L, Gu F, et al
    Covalently assembled dual-functional triple-helix lentinan-Au for cervical cancer therapy.
    Carbohydr Polym. 2026;375:124799.
    PubMed    
    Abstract available

  14. TUERXUN H, Li J, Liu Q, Tursun M, et al
    MICA/B-Driven NK Cell Dysfunction Promotes Cervical Cancer via Toll Signaling.
    Exp Cell Res. 2025 Dec 29:114876. doi: 10.1016/j.yexcr.2025.114876.
    PubMed    
    Abstract available

  15. REN Y, Li S, Xiang S, Xu J, et al
    A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma.
    Cancer Med. 2026;15:e71488.
    PubMed    
    Abstract available

  16. SHARMA H, Soni KK, Thakur N, Kumar M, et al
    Intracavitary brachytherapy challenge in cervical cancer with a large cervical fibroid: A case report.
    J Cancer Res Ther. 2025;21:1431-1434.
    PubMed    
    Abstract available

  17. ABRAHAM P
    Human Papillomavirus Vaccination - A Moment of Prevention, a Lifetime of Protection.
    Indian J Public Health. 2025;69:375-376.
    PubMed    
    Abstract available

  18. KIM CA, Shelton N, Samudrala M, Savsani K, et al
    AutoEpiCollect 2.0: A Web-Based Machine Learning Tool for Personalized Peptide Cancer Vaccine Design.
    Molecules. 2025;30:4702.
    PubMed    
    Abstract available

  19. KIM MH, Yang J, Song DH, Kim CH, et al
    Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters.
    Medicina (Kaunas). 2025;61:2134.
    PubMed    
    Abstract available

  20. TERKIMBI SD, Paul-Chima UO, Mujinya R, Joan C, et al
    Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management.
    Infect Agent Cancer. 2025 Dec 30. doi: 10.1186/s13027-025-00729.
    PubMed    


  21. HOSHINO N, Yoshida K, Kanemitsu Y, Toyama A, et al
    Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer.
    Anticancer Res. 2026;46:273-281.
    PubMed    
    Abstract available

  22. OOMMEN AM, Ashfaq M, Tonsing MV, Cherian AG, et al
    Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN).
    BMJ Open. 2025;15:e101599.
    PubMed    
    Abstract available

  23. ABASCAL MIGUEL L, Gaitan Barrillas R, Johnston JS, Ward V, et al
    HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study.
    BMJ Open. 2025;15:e107602.
    PubMed    
    Abstract available

  24. PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
    Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
    Obstet Gynecol Surv. 2025;80:759-761.
    PubMed    
    Abstract available

  25. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
    Obstet Gynecol Surv. 2025;80:702-704.
    PubMed    
    Abstract available

  26. MKUU RS, Tohme S, Rivero-Mendoza D, Salloum RG, et al
    Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer.
    Cancer Manag Res. 2025;17:3273-3284.
    PubMed    
    Abstract available

  27. DONG S, Feng YN, Li XY, Peng YQ, et al
    An Ultrasound Radiomics Model for the Early Diagnosis of Cervical Cancer.
    Ultrason Imaging. 2025 Dec 29:1617346251403960. doi: 10.1177/01617346251403960.
    PubMed    
    Abstract available

  28. YAN Q, Zhang Z, Li R, Xue J, et al
    Clinical and nutritional-inflammatory biomarkers-based nomogram predicts survival in recurrent or metastatic cervical cancer treated with immune checkpoint inhibitors.
    Ann Med. 2026;58:2603780.
    PubMed    
    Abstract available

  29. OOMMEN AM, Ashfaq M, Viswanathan V, Singarayar P, et al
    Readiness to transition to HPV self-collection from VIA screening: a mixed methods health systems assessment from Tamil Nadu, India.
    BMC Health Serv Res. 2025;25:1619.
    PubMed    
    Abstract available

  30. ISMAEL AMEEN S, Masoudi M, Azizi H, Skutella T, et al
    HPV-Driven Immune Evasion in Cervical Cancer: Transcriptomic Identification of Downregulated Hub Genes and Suppressed Leukocyte Migration Pathways.
    Int J Mol Sci. 2025;26:12121.
    PubMed    
    Abstract available

  31. RODRIGUEZ-NAVA C, Cortes-Sarabia K, Riano-Umbarila L, Becerril-Lujan B, et al
    Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma.
    Int J Mol Sci. 2025;26:11946.
    PubMed    
    Abstract available

  32. OPLAWSKI M, Mawlichanow K, Golec-Cera A, Jedrzejczyk A, et al
    Outcomes of Cervical Cancer Treatment Using Total Mesometrial Resection (TMMR) Performed with the Robotic System-A Preliminary Report.
    J Clin Med. 2025;14:8667.
    PubMed    
    Abstract available

  33. GRIECO V, Fiorito D, Giorgianni G, Irato E, et al
    HPV Vaccine: An Effective but Underutilized Prevention Tool.
    Int J Environ Res Public Health. 2025;22:1844.
    PubMed    
    Abstract available

  34. GISCA T, Matasariu DR, Ursache A, Socolov DG, et al
    Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review.
    Diagnostics (Basel). 2025;15:3231.
    PubMed    
    Abstract available

  35. JIANG Y, Wei Y, Li Z, Huang Z, et al
    Enhancing CD8(+) T Cells Infiltration Through the Protein Arginine Methyltransferase 5 (PRMT5)/CXCL10 Axis Restricts Cervical Cancer Progression.
    Biomolecules. 2025;15:1717.
    PubMed    
    Abstract available

  36. PHIANPISET R, Detwongya C, Phookiaw S, Manopunya M, et al
    Long-Term Oncological Outcomes of Laparoscopic Versus Open Radical Surgery in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
    Cancers (Basel). 2025;17:3960.
    PubMed    
    Abstract available

  37. SANTOS F, Caramelo FA, Tomaz JMP, Santana MM, et al
    Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2025;17:3945.
    PubMed    
    Abstract available

  38. SONG Y, Zou K, Zou L
    Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer.
    Cancers (Basel). 2025;17:3934.
    PubMed    
    Abstract available

  39. GACUTA E, Lawicki M, Grabowska H, Lawicki P, et al
    Role of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) in Diagnosing Cervical Cancer Patients.
    Biomedicines. 2025;13:2910.
    PubMed    
    Abstract available

  40. RUHODE N, Madanhire C, Tumushime MK, Gudukeya S, et al
    Perceptions of integrating cervical cancer screening with HIV and sexual and reproductive health services: results from serial multiple methods studies among health workers and women in Zimbabwe.
    Reprod Health. 2025;22:259.
    PubMed    
    Abstract available

  41. A AMER A, Altabbaa H, Sh Ramadan M, Abdul-Hafez HA, et al
    A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East.
    Sci Rep. 2025 Dec 29. doi: 10.1038/s41598-025-30866.
    PubMed    


  42. FANT C, Tewari K
    Eradicating cervical cancer in the poorest regions of the world.
    Curr Opin Obstet Gynecol. 2026;38:6-13.
    PubMed    
    Abstract available

  43. RAO S, R S, Sarma D, Nath AG, et al
    HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres?
    Asian Pac J Cancer Prev. 2025;26:4513-4523.
    PubMed    
    Abstract available

  44. BOMUANG K, Saengkhiao M, Chaimay B, Woradet S, et al
    Health Literacy and Factors Associated with HPV Vaccination among Adolescent Students: A Cross-Sectional Analytic Study.
    Asian Pac J Cancer Prev. 2025;26:4387-4396.
    PubMed    
    Abstract available

  45. SINGH N, Mangal S, Tanwar P, Singhal S, et al
    Evaluating The Feasibility and Acceptability of Cervical Cancer Screening in an Urban Slum Community by HPV Self-Sampling With the Aid of Telecounselling: Lessons Learnt.
    Asian Pac J Cancer Prev. 2025;26:4331-4338.
    PubMed    
    Abstract available

  46. LEE HY, Chipalo E, Luo Y, Chou C, et al
    Determinants of Female Cancer Screening Awareness in Alabama's Black Belt Region.
    Asian Pac J Cancer Prev. 2025;26:4313-4322.
    PubMed    
    Abstract available

  47. K C BHANDARI A, Htay ZW, Parvin R, Murakami M, et al
    Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:4269-4281.
    PubMed    
    Abstract available

  48. KRYLYSHKIN M, Chernyakov A, Dil O, Truschuk J, et al
    Radical Trachelectomy Using A Titanium-Nickelide Metal Tricotage Implant to Preserve Fertility in Cervical Cancer Patients.
    Asian Pac J Cancer Prev. 2025;26:4265-4268.
    PubMed    
    Abstract available

  49. AZHARI HA, Chawdhury M, Islam F, Zakaria GA, et al
    Visual inspection with acetic acid and colposcopy: screening of cervical cancer in resource-limited healthcare settings.
    Front Glob Womens Health. 2025;6:1684205.
    PubMed    
    Abstract available

  50. WU X, Wang D, Mao X, Dong B, et al
    Microbiome-Driven Resistance in Cervical Cancer Therapy: From Mechanistic Dissection to Clinical Translation.
    Expert Rev Mol Med. 2025 Dec 29:1-45. doi: 10.1017/erm.2025.10029.
    PubMed    


  51. BLETSAS M, Rodrigues M
    [Tisotumab Vedotin - Metastatic or recurrent cervical cancer as second-line therapy].
    Bull Cancer. 2025 Dec 27:S0007-4551(25)00534.
    PubMed    


  52. ZHANG J, Zhao J, Cui RR, Wang TT, et al
    [Clinical outcomes of people with abnormal cervical cancer screening results but normal colposcopy findings].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:958-967.
    PubMed    
    Abstract available

  53. SULTANOV M, Pan F, Naheed N, Rahman A, et al
    Costing of Cervical Cancer Screening and Treatment Pathways: Case Studies in Bangladesh and Uganda.
    Value Health Reg Issues. 2025;54:101566.
    PubMed    
    Abstract available

  54. MANGA SM, Lee GM, Ekoue N, Simeni MH, et al
    Prevalence of human papillomavirus and cervical neoplasia among women who have sex with women in Cameroon: A descriptive study.
    Afr J Reprod Health. 2025;29:122-130.
    PubMed    
    Abstract available

  55. PAKDAMAN K, Esmaeilnia Shirvani A, Pakdaman K, Karim B, et al
    Systematic review and meta analysis of the global incidence and clinicopathological characteristics of liver metastasis in patients with cervical cancer.
    Discov Oncol. 2025 Dec 27. doi: 10.1007/s12672-025-04255.
    PubMed    


  56. ADEKUNLE TE, Adekunle TB, Thomas S
    Black Women's Perceptions of the Challenges Surrounding Cervical Cancer Screening in the United States.
    J Racial Ethn Health Disparities. 2025 Dec 27. doi: 10.1007/s40615-025-02809.
    PubMed    
    Abstract available

  57. YIN J, Zhang S, Wang S, Li Z, et al
    Age-specific clinical performance of HPV-based vs. cytology-based cervical cancer screening in China.
    Nat Commun. 2025 Dec 27. doi: 10.1038/s41467-025-67215.
    PubMed    
    Abstract available

  58. MONTECILLO JAV, Yoo HJ, Lee YY, Park CM, et al
    Streptococcus vaginalis affects cellular dynamics of cervical cancer cells via oxidative stress-induced activation of endoplasmic reticulum unfolded protein response.
    Microbiol Res. 2025;305:128433.
    PubMed    
    Abstract available

  59. VILLARREAL XP, He R, Valle D, Kioutchoukova IP, et al
    Preferences of High-Risk HPV-Based Cervical Cancer Screening among Transgender Men and Gender Diverse People Assigned Female at Birth: A Cross-Sectional Study at a Single Academic Center.
    Cancer Causes Control. 2025;37:12.
    PubMed    
    Abstract available

  60. SULTANA F, Chatterjee N, Mukherjee D, Kumar Panda C, et al
    Role of miRNAs, miR-135b-5p & miR-21-5p in metastasis of cervical cancer.
    Indian J Med Res. 2025;162:493-503.
    PubMed    
    Abstract available

  61. CORREA CM, Zeferino LC, Juliato CT, Bahamondes L, et al
    Association of cervical cancer and intrauterine device use: a narrative review.
    BMC Womens Health. 2025 Dec 27. doi: 10.1186/s12905-025-04239.
    PubMed    
    Abstract available

  62. LI L, Lin D, Ao K, Zhong S, et al
    YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.
    Cell Death Dis. 2025 Dec 26. doi: 10.1038/s41419-025-08188.
    PubMed    
    Abstract available

  63. TODOROVA I, Panayotova Y, Kotzeva T, Greenley R, et al
    Cervical cancer in Bulgaria since EU accession in 2007: a struggle in the face of political instability.
    Health Policy. 2026;164:105497.
    PubMed    
    Abstract available

  64. HOLDERNESS H, Kaufmann J, Erroba J, Marino M, et al
    Changes in breast and cervical cancer screening rates among Latinas after Medicaid expansion.
    Am J Prev Med. 2025 Dec 24:108241. doi: 10.1016/j.amepre.2025.108241.
    PubMed    
    Abstract available

  65. FLANAGAN M, Fantasia HC
    A Multicomponent, Team-Based Quality Improvement Project for Improving Cervical Cancer Screenings in Primary Care.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00204.
    PubMed    
    Abstract available

  66. KIM SK, Fontenot HB
    The Potential of Human Papillomavirus Self-Collection Testing to Improve Cervical Cancer Screening Among Women Living With HIV.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00211.
    PubMed    
    Abstract available

  67. AKBARI P, Ali HA, Negahi M, Frimayanti N, et al
    Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line.
    Med Oncol. 2025;43:79.
    PubMed    
    Abstract available

  68. SHAH A, Kotadia B, Padmanaban R, Patel R, et al
    Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
    Indian J Community Med. 2025;50:933-938.
    PubMed    
    Abstract available

  69. CHEN T, Zhen L, Su Y, Yi H, et al
    Nomogram for predicting urinary retention after radical hysterectomy for cervical cancer with comparative analysis of surgical methods.
    Pak J Med Sci. 2025;41:3485-3492.
    PubMed    
    Abstract available

  70. GONG P, Wang H, Wang Y
    Efficacy of laparoscopic versus open abdominal radical hysterectomy on stress response and urodynamic status in patients with early cervical cancer.
    Pak J Med Sci. 2025;41:3359-3364.
    PubMed    
    Abstract available

  71. PERELMUTER S, Balogun O
    The global need for brachytherapy innovation in cervical cancer.
    Brachytherapy. 2025 Dec 24:S1538-4721(25)00361.
    PubMed    


  72. SHI Y, Zhang Z, Di X, Shen G, et al
    Integrative analysis of single-cell and bulk transcriptomes reveals metabolic heterogeneity and identifies PFKP as a therapeutic target in cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2025 Dec 23:168146.
    PubMed    
    Abstract available

  73. SHEWALKAR BK, Pant P, Patel J, Patil A, et al
    Neoadjuvant Chemotherapy Followed by Interdigitated Brachytherapy versus Standard Chemoradiation in Locally Advanced Cervical Cancer.
    South Asian J Cancer. 2025;14:404-410.
    PubMed    
    Abstract available

  74. BABU MS, Kasting ML, Rodriguez NM
    Patient attitudes toward HPV self-sampling and community health worker-delivered cervical cancer screening services in an underserved area.
    J Clin Transl Sci. 2025;9:e270.
    PubMed    
    Abstract available

  75. BEN ZUR T, Gutvirtz G, Meirovitz M, Davidesko S, et al
    [Cervical Conization and the Future Risk for Preterm Labor and Cesarean Delivery].
    Harefuah. 2025;165:627-632.
    PubMed    
    Abstract available

  76. EMON HH, Kowbi RN, Chowdhury MN, Teep TR, et al
    Assessing knowledge, attitudes, and barriers toward HPV cervical cancer and vaccination among female university students in Bangladesh.
    Sci Rep. 2025;15:44529.
    PubMed    
    Abstract available

  77. CAI L, Luo X, Wu C, Deng X, et al
    Prognostic value of ultrasonography findings in patients with cervical cancer.
    Sci Rep. 2025;15:44471.
    PubMed    
    Abstract available

  78. STRAATHOF R, Pool LI, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
    Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression.
    Brachytherapy. 2025 Dec 23:S1538-4721(25)00360.
    PubMed    
    Abstract available

  79. ASANO Y, Nishihara C, Kitayama T, Okawa N, et al
    MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix.
    Acta Med Okayama. 2025;79:463-468.
    PubMed    
    Abstract available

  80. BROTHERTON JML, LaMontagne DS, Bloem PJN
    Global status of HPV vaccination two decades in: effective, safe and preventing cancer.
    Expert Rev Vaccines. 2026;25:2609869.
    PubMed    
    Abstract available

  81. NAKASHIMA T, Matsumoto K, Yoshitake T, Kunitake N, et al
    Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study.
    Jpn J Radiol. 2025 Dec 24. doi: 10.1007/s11604-025-01923.
    PubMed    
    Abstract available

  82. ZHU M, Liu J, Wang Y, Lu H, et al
    Prognostic Significance of Complete Blood Count-Derived Inflammatory Biomarkers in Patients with Small Cell Neuroendocrine Carcinoma of the Cervix.
    Curr Oncol. 2025;32:654.
    PubMed    
    Abstract available

  83. PACHOLCZAK-MADEJ R, Lisik-Habib M, Madry R, Szarszewska M, et al
    Real-world outcomes of immune checkpoint inhibitor monotherapy in later lines of recurrent/metastatic cervical cancer - evidence from a rescue access program in Poland.
    Contemp Oncol (Pozn). 2025;29:384-392.
    PubMed    
    Abstract available

  84. LIU Z, Zhang S, Wang Y, Zong Y, et al
    Development and validation of immunotherapy nomogram for predicting the efficacy and prognosis of recurrent and metastatic cervical cancer.
    Front Immunol. 2025;16:1662605.
    PubMed    
    Abstract available

  85. ZHOU D, Wang R, Huang L, Yan P, et al
    Real-world efficacy assessment for sintilimab in recurrent or metastatic cervical cancer.
    PeerJ. 2025;13:e20477.
    PubMed    
    Abstract available

  86. HE Q, Xiao L, Lan Y, Yao D, et al
    Analysis of the Development Trajectory and Influencing Factors of Depression in Patients With Cervical Cancer During Concurrent Chemoradiotherapy.
    Actas Esp Psiquiatr. 2025;53:1366-1374.
    PubMed    
    Abstract available

  87. FUJISAKI M, Matsumoto K
    [Latest Drug Therapies for Cervical Cancer].
    Gan To Kagaku Ryoho. 2025;52:858-863.
    PubMed    
    Abstract available

  88. SHAN H, Xu Q
    Prognostic significance of pretreatment systemic immune-inflammation index (SII) in patients with cervical cancer: a meta-analysis.
    World J Surg Oncol. 2025 Dec 23. doi: 10.1186/s12957-025-04167.
    PubMed    


  89. CHOPRA S, Samanta A, Nagar A, Mittal P, et al
    Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic.
    Brachytherapy. 2025 Dec 22:S1538-4721(25)00365.
    PubMed    
    Abstract available

  90. YOSHIDA-COURT K, Teka B, Cisneros Napravnik T, Karpinets T, et al
    Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer.
    JCO Glob Oncol. 2025;11:e2500060.
    PubMed    
    Abstract available

  91. HUANG Q, Wang F, Li X, Zou W, et al
    Multi-omics profiling reveals an immunosuppressive plasma cell subset within tertiary lymphoid structures in cervical cancer.
    Cancer Immunol Immunother. 2025;75:26.
    PubMed    
    Abstract available

  92. KUMAR P, Ray A, Hora R, Kumari A, et al
    Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis.
    Inquiry. 2025;62:469580251399368.
    PubMed    
    Abstract available

  93. SUJAY PS, Balaji R
    GC-MS and in silico analysis reveal astaxanthin, nimbin, and gamma-sitosterol from Nyctanthes arbor-tristis flowers as dual modulators of HPV E6 and p53 in cervical cancer.
    In Silico Pharmacol. 2025;14:9.
    PubMed    
    Abstract available

  94. NAVA M, Earl J, Patel H, Canizares M, et al
    Cancer Disparities and the Political Economy of Healthcare Access: A County-Level Analysis in a High-Disparity County.
    J Prim Care Community Health. 2025;16:21501319251406402.
    PubMed    
    Abstract available

  95. PAN M, Yi T, Lei P, Mo J, et al
    Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.
    J Cell Mol Med. 2025;29:e70968.
    PubMed    
    Abstract available

  96. WU X, Wang B, Liu L, Chen Z, et al
    Multi-omics analysis reveals that knockdown of IMPA2 induces apoptosis in cervical cancer cells through ROS/MYC/CDK1 signaling.
    Clin Transl Oncol. 2025 Dec 22. doi: 10.1007/s12094-025-04167.
    PubMed    
    Abstract available

  97. CHEN G, Zhang W, HuYan Y, Yang Y, et al
    Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening.
    Diagn Pathol. 2025 Dec 22. doi: 10.1186/s13000-025-01744.
    PubMed    
    Abstract available

  98. MIDAKSA M, Destaw A, Getachew S, Tamrat D, et al
    Health system challenges in the diagnostic and treatment pathway for patients with suspected cervical cancer: a qualitative study.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13918.
    PubMed    


  99. ZHANG L, Yang Q, Zhu H, Zheng Z, et al
    Cadonilimab plus chemotherapy compared to chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer in China: a cost-effectiveness analysis.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13871.
    PubMed    


  100. MANDIWA C, Sanna M, Gao W
    Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.
    BMC Womens Health. 2025;25:603.
    PubMed    
    Abstract available

  101. ZHANG L, Fan X, Ma J, Zhang J, et al
    Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy.
    Nat Commun. 2025;16:11565.
    PubMed    
    Abstract available

  102. WANG J, Liu S, Li P, Negrin YP, et al
    Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer.
    Cell Death Dis. 2025;16:920.
    PubMed    
    Abstract available

  103. WANG W, Yang G, Liu Y, Wei L, et al
    Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
    NPJ Digit Med. 2025;8:774.
    PubMed    


  104. KIRUBA B, Raja Karthikeyan RRR, Anilkumar SR, Sundararajan V, et al
    Implications of Single-Cell RNA Sequencing in Cervical Cancer: Unravelling the Molecular Landscape.
    ACS Omega. 2025;10:60080-60093.
    PubMed    
    Abstract available

  105. HUANG C, Qiu Y, Huang X, Tang H, et al
    A digital health intervention: development and validation of a social media nursing program for sexual dysfunction following cervical cancer radical hysterectomy.
    Front Public Health. 2025;13:1720263.
    PubMed    
    Abstract available

  106. MONDAL J, Chatterjee R, Kumar Gourisaria M, Sahni M, et al
    Cervical cancer classification using a novel hybrid approach.
    Front Oncol. 2025;15:1703772.
    PubMed    
    Abstract available

  107. YAN HY, Shen XP, Tao PP, Jin L, et al
    Deep learning models for cervical cancer subtyping using whole slide images.
    Front Oncol. 2025;15:1574639.
    PubMed    
    Abstract available


  108. Retraction: MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
    Oncol Res. 2025;33:4157.
    PubMed    
    Abstract available

  109. HE G, Huang Y, Zhang X, Yuan L, et al
    Landscape Analysis of Human Papillomavirus (HPV) Prophylactic Vaccine Clinical Trials in China Based on the NMPA Database.
    Drug Des Devel Ther. 2025;19:11245-11257.
    PubMed    
    Abstract available

  110. CRABB K, Okwesa J, Yap JKW, Kwong FL, et al
    Challenges in managing cervical cancer in pregnancy: Three case reports.
    Case Rep Womens Health. 2025;48:e00765.
    PubMed    
    Abstract available

  111. DEWAN SMR, Proma AY, Khan SA, Meem SS, et al
    Evaluation of the Association of TNF-alpha rs361525 Gene Polymorphism in Bangladeshi Patients With Breast and Cervical Cancer: A Case-Control Study and Meta-Analysis.
    Health Sci Rep. 2025;8:e71653.
    PubMed    
    Abstract available

  112. BERKEL C
    Radiotherapy or chemoradiotherapy might sensitize cervical cancer cells to plasma membrane rupture during necroptosis by upregulating the expression of SIGLEC12, a recently identified membrane-rupturing protein.
    Hum Cell. 2025;39:24.
    PubMed    


  113. OZBAS S, Gerey S, Koc SO
    Attitudes Towards Early Diagnosis of Cervical Cancer Among Women Applying to a Health Institution in Turkey.
    J Obstet Gynaecol Res. 2025;51:e70174.
    PubMed    
    Abstract available

  114. SORMANI J, Moukam A, Wisniak A, Yakam V, et al
    Psychological and sexual impact of human papillomavirus screening in women in Cameroon: a prospective cohort study.
    BMC Womens Health. 2025;25:602.
    PubMed    
    Abstract available

  115. PEREIRA D, Almeida AM, Queiroz JA, Sousa F, et al
    Innovative minicircle DNA vector encoding pri-miR-375 silences E6 and E7 oncoproteins in HPV16-positive CaSki cells.
    Gene. 2026;981:149964.
    PubMed    
    Abstract available

  116. DHUSIYA HR, Sethy P, Pati S, Pradhan SK, et al
    How can the uptake of HPV vaccination be increased in school going girls? a qualitative study with multiple stakeholders in Ganjam, Odisha.
    Int J Adolesc Med Health. 2025;37:421-430.
    PubMed    
    Abstract available

  117. PANG D, Zhang S, Yang H, Liang K, et al
    (18)F-FDG PET radiomics for predicting progression-free survival in locally advanced cervical squamous cell carcinoma.
    Hell J Nucl Med. 2025;28:232-245.
    PubMed    
    Abstract available

  118. PEREZ BIANCHI P, Anselmo S, Vasquez Currie M, Medel J, et al
    RIVA: An Image Dataset of Conventional Pap Smear Cytology with Multiple Independent Annotations.
    Sci Data. 2025;12:1991.
    PubMed    
    Abstract available

  119. CHEN X, Wang S, Ding B, Nie Y, et al
    Dibutyl phthalate (DBP) induces cervical injury and promotes malignant transformation of cervical epithelial cells.
    Food Chem Toxicol. 2026;208:115885.
    PubMed    
    Abstract available

  120. IKEMOTO A, Uchiyama T, Takeda M, Nakamine H, et al
    Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.
    J Clin Exp Hematop. 2025;65:312-317.
    PubMed    
    Abstract available

  121. MOHAMMADI M, Fell C, Morrison D, Bell S, et al
    Cervical whole-slide images dataset for multiclass classification.
    Gigascience. 2025;14:giaf144.
    PubMed    
    Abstract available

  122. ZHU L, Wu Z, Shi S, Xue H, et al
    Dysbiosis of vaginal and peritoneal fluid microbiota in patients with cervical lesions.
    BMC Womens Health. 2025;25:631.
    PubMed    
    Abstract available

  123. FEREDE KG, Bantie B, Abdu AM, Ferede AG, et al
    Prevalence and predictors of cervical lesions among women on ART in the Awi Zone, Northwest Ethiopia: facility-based cross-sectional study.
    BMC Womens Health. 2025;25:622.
    PubMed    
    Abstract available

  124. ESCOBAR V, Catalan A, Callejas V, Araya R, et al
    Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile.
    BMC Womens Health. 2025;25:617.
    PubMed    
    Abstract available

  125. CHEN M, Wu Y, Wang L, Li L, et al
    A non-inferiority study of 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) for high-grade squamous intraepithelial lesions of the cervix in patients of childbearing age: A non-randomized controlled prospective study.
    Photodiagnosis Photodyn Ther. 2025;56:105280.
    PubMed    
    Abstract available

  126. BANNOUR I, Mastouri S, Bannour R, Saoudi R, et al
    HPV vaccination: analysis of acceptability among mothers - a study of 160 cases.
    Int J Adolesc Med Health. 2025;37:389-396.
    PubMed    
    Abstract available

  127. CHEN M, Li H, Wang L, Li L, et al
    Comparison of the efficacy of photodynamic therapy alone and photodynamic therapy after laser pretreatment for high-grade cervical intraepithelial lesions in women of childbearing age: a prospective study.
    Photodiagnosis Photodyn Ther. 2025;56:105260.
    PubMed    
    Abstract available

  128. SUN B, Chen Y, Cao D, Xu Y, et al
    Evaluation of the efficacy of carbon dioxide laser combined with 5-aminolevulinic acid photodynamic therapy in treating high-grade vaginal squamous intraepithelial lesions following hysterectomy.
    Photodiagnosis Photodyn Ther. 2025;56:105256.
    PubMed    
    Abstract available

  129. WANG X, Chen Y, Xu X, Huang J, et al
    Evaluation of the efficacy of topical photodynamic therapy against cervical HPV infection.
    Photodiagnosis Photodyn Ther. 2025;56:105250.
    PubMed    
    Abstract available

  130. YUAN S, Zhang M, Zhang C, Su Y, et al
    Effect of topical photodynamic therapy with 5-aminolevulinic acid in the treatment of high-risk cervical low-grade squamous intraepithelial lesions.
    Photodiagnosis Photodyn Ther. 2025;56:105248.
    PubMed    
    Abstract available

  131. SIERRA MS, Coto C, Porras C, Herrero R, et al
    Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories.
    J Infect Dis. 2025;232:e906-e915.
    PubMed    
    Abstract available

  132. HETLAND FALKENTHAL TE, Nygard S, Nygard M
    Beyond Women's Health: Long-Term HPV-related Cancer Trends in Norway.
    J Infect Dis. 2025 Jul 9:jiaf351. doi: 10.1093.
    PubMed    
    Abstract available

  133. CHEN M, Guo J, Xu B
    Targeted Fluorescent Polysaccharide Platform for Solute Carrier Protein PCNA Detection and Cervical Squamous Cell Carcinoma Inhibition.
    J Fluoresc. 2025;35:11539-11552.
    PubMed    
    Abstract available

  134. CHENG E, Stubbs JM, Achat HM
    Self-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.
    Public Health Rep. 2026;141:43-50.
    PubMed    
    Abstract available

  135. KESZTHELYI M, Sziva RE, Havran Z, Szabo V, et al
    Systemic Inflammatory Indices-Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)-As Potential Rule-Out Biomarkers for Invasive Cervical Carcinoma.
    Int J Mol Sci. 2025;27:435.
    PubMed    
    Abstract available

  136. ALVARADO-CAMACHO DA, Castillo-Velazquez R, Granados-Lopez AJ, Hernandez-Lopez H, et al
    Differentially Expressed Genes Associated with the Development of Cervical Cancer.
    Int J Mol Sci. 2025;27:258.
    PubMed    
    Abstract available

  137. WANG M, Cao Y, Zhang W, Liang Y, et al
    Prediction Model of Lymph Node Metastasis in Cervical Cancer Based on MRI Habitat Radiomics.
    Cancers (Basel). 2025;18:152.
    PubMed    
    Abstract available

  138. GORECKI G, Hale M, Taylor S, Garcia G, et al
    Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.
    Cancers (Basel). 2025;18:129.
    PubMed    
    Abstract available

  139. SEMINARIO N, Bebia V, Luzarraga Aznar A, Jose MS, et al
    Postvoid Residual Volume After Radical Hysterectomy for Early-Stage Cervical Cancer: Predictive Factors and a Decision-Making Algorithm.
    Cancers (Basel). 2025;18:24.
    PubMed    
    Abstract available

  140. FAN C, Fu C
    Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies.
    J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  141. WANG S, Zhu Q, Lu Y, Yang X, et al
    Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.
    J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  142. LOVKIEL A, Petersen LK
    Increasing cervical cancer screening participation: a cluster-randomized pilot study at a department of gynaecology.
    BMC Womens Health. 2026 Jan 9. doi: 10.1186/s12905-025-04250.
    PubMed    


  143. WANG L, Li X, Ren C, Liu L, et al
    Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1/S1P/S1PR1 pathway.
    Cell Death Dis. 2026;17:24.
    PubMed    
    Abstract available

  144. LAN C, Zhang P, Zhao J, Li Q, et al
    Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.
    Cancer Discov. 2026 Jan 9. doi: 10.1158/2159-8290.CD-25-0467.
    PubMed    
    Abstract available

  145. DA SILVA LOUZA LG, de Sousa Gomes ML, Oria MOB, Rafael EV, et al
    Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.
    Cancer Causes Control. 2026;37:16.
    PubMed    
    Abstract available

  146. LIU J, Lei L, Liu Y, Wu J, et al
    Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1.
    Appl Biochem Biotechnol. 2026 Jan 9. doi: 10.1007/s12010-025-05535.
    PubMed    


  147. WANG K, Si L, Zhao M, Guo R, et al
    Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.
    Arch Gynecol Obstet. 2026;313:23.
    PubMed    
    Abstract available

  148. ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
    Nutritional Status of Patients Diagnosed with Cervical Cancer in Tanzania.
    Res Sq [Preprint]. 2025 Dec 18:rs.3.rs-7780798. doi: 10.21203/rs.3.rs-7780798.
    PubMed    
    Abstract available

  149. ZHANG LL, Ji YF, Li J, Wang WH, et al
    Construction of a prognostic model based on efferocytosis for predicting survival and immunotherapy efficacy in cervical cancer.
    Transl Cancer Res. 2025;14:8908-8929.
    PubMed    
    Abstract available

  150. PAI N, Rao JS
    Data-based clustering in prediction of cervical cancer DNA methylation using pan-cancer genetic and clinical data.
    Bioinform Adv. 2025;6:vbaf316.
    PubMed    
    Abstract available

  151. BEREZA K, Banas T, Grabarek BO, Czerw A, et al
    Levels of Systemic Inflammatory Markers in Women with Cervical Cancer Undergoing Definitive Chemoradiotherapy Depend Primarily on Pre-treatment and Post-teletherapy Tumor Volume, Rather than on the Prescribed Radiation Dose.
    Curr Pharm Biotechnol. 2026 Jan 6. doi: 10.2174/0113892010413911251122074226.
    PubMed    
    Abstract available

  152. XIN W, Zhang J, Wu D, Cai Y, et al
    VAMP7-mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection.
    Clin Transl Med. 2026;16:e70590.
    PubMed    
    Abstract available

  153. OYARO B, Wanje G, Richardson BA, Temmerman M, et al
    A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Ke
    Implement Sci Commun. 2026 Jan 9. doi: 10.1186/s43058-025-00852.
    PubMed    
    Abstract available

  154. ZONG Y, Zhang D, Li Y, Wang P, et al
    Rare early-onset radiation-induced lumbosacral plexopathy in cervical cancer: a case report.
    BMC Neurol. 2026 Jan 8. doi: 10.1186/s12883-025-04601.
    PubMed    


  155. LI F, Wei Z, Tao M, Zhao K, et al
    Notch1(+) cervical cancer cells may promote perineural invasion by secreting neurotrophin-4.
    Sci Rep. 2026 Jan 8. doi: 10.1038/s41598-025-34812.
    PubMed    


  156. FAN QQ, Qin HF, Liu YQ
    Artemisinin Inhibits Drug Resistance and Epithelial-Mesenchymal Transition in Cervical Cancer Cells via the Wnt/beta-Catenin Signaling Pathway.
    Bull Exp Biol Med. 2026 Jan 8. doi: 10.1007/s10517-026-06540.
    PubMed    
    Abstract available

  157. ZHANG R, Chai S, Zhang F, Lai J, et al
    Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation.
    Cell Death Discov. 2026;12:4.
    PubMed    
    Abstract available

  158. PEPPA V, Robitaille M, Akbari F, Enger SA, et al
    Clinical test cases for commissioning, QA, and benchmarking of model-based dose calculation algorithms in (1)(9)(2)Ir HDR gynecologic tandem and ring brachytherapy.
    Med Phys. 2026;53:e70260.
    PubMed    
    Abstract available

  159. OSHIKANLU BC, Sowunmi AC, Habeebu MY, Dada AO, et al
    Serum Squamous Cell Carcinoma Markers: A Case-Control Study for Cervical Cancer.
    Clin Med Res. 2025;23:129-136.
    PubMed    
    Abstract available

  160. FANG H, Mu J, Chow EP, Ong JJ, et al
    Chinese caregivers' preferences and predicted uptake of HPV vaccination: a study protocol for two discrete choice experiments.
    BMJ Open. 2026;16:e089565.
    PubMed    
    Abstract available

  161. VAN LONKHUIJZEN L, Mom CH, van der Aa M
    Cervical cancer in women eligible for HPV-vaccination in the Netherlands.
    J Gynecol Obstet Hum Reprod. 2026 Jan 6:103107. doi: 10.1016/j.jogoh.2026.103107
    PubMed    


  162. SEEMAAB A, Colaizzi A, Matsko J, Ye Y, et al
    Assessment of microorganism detection in ThinPrep Papanicolaou tests utilizing the Hologic Genius Digital Diagnostics System.
    Am J Clin Pathol. 2025;164:946-952.
    PubMed    
    Abstract available

  163. GANGULY AP, Pretsch PK, Brewer NT, Spees LP, et al
    Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus: A Single-Group Secondary Analysis of a Randomized Clinical Trial.
    JAMA Netw Open. 2026;9:e2551345.
    PubMed    
    Abstract available

  164. KITAMI K, Kuji S, Kamiya N, Machida H, et al
    Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study.
    Int J Clin Oncol. 2026 Jan 8. doi: 10.1007/s10147-025-02951.
    PubMed    
    Abstract available

  165. MURUGAIYAN K, Srivastava R, Balaraman J, Eswar K, et al
    Gold-Coated Glybosomes Mimicking Physiological Micelles for ROS-Mediated Photothermal Ablation against Cervical Cancer.
    ACS Appl Bio Mater. 2026 Jan 8. doi: 10.1021/acsabm.5c02289.
    PubMed    
    Abstract available

  166. OLTHOF EP, Oostveen NA, van der Aa MA, Bekkers RLM, et al
    Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
    Gynecol Oncol Rep. 2025;63:102002.
    PubMed    
    Abstract available

  167. JURJUT O, Weiss M, Daniel Y, Matovina S, et al
    Detection of Cervical Intraepithelial Neoplasia Using Hyperspectral Tissue Signatures.
    IEEE J Transl Eng Health Med. 2025;13:532-539.
    PubMed    
    Abstract available

  168. SINNO AK, Mustapha A, Nair N, Zaami S, et al
    Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives.
    Oncol Res. 2025;34:4.
    PubMed    
    Abstract available

  169. JIANG C, Rosenberg PS, Jemal A, Sung H, et al
    Cervical cancer incidence rates by birth cohort against the backdrop of human papillomavirus vaccination in the United States.
    J Natl Cancer Inst. 2026 Jan 7:djaf374. doi: 10.1093.
    PubMed    
    Abstract available

  170. LU R, Zhang J, Ma X, Feng Y, et al
    Dual-dimensional profiling of host genomic variations and HPV integration in PD-L1-stratified cervical cancer via Oxford Nanopore Technology.
    J Transl Med. 2026 Jan 7. doi: 10.1186/s12967-025-07674.
    PubMed    


  171. PATEL MS, Patel KS, Willmann J, Feliciano EJG, et al
    Cervical cancer screening beyond traditional barriers.
    Lancet Public Health. 2026;11:e6.
    PubMed    


  172. MEGLIC E, Ploner A, Clements M, Elfstrom M, et al
    Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: a population-based cohort study in Sweden.
    Lancet Public Health. 2026;11:e35-e43.
    PubMed    
    Abstract available

  173. LI H, Ahmad M, Zhou D
    Relaxin-2 Inhibits Cervical Cancer Growth by Downregulating Kruppel-Like Factor 5 (KLF5) Through the Inhibition of Hippo-YAP and JAK2/STAT3 Signaling Pathways.
    J Biochem Mol Toxicol. 2026;40:e70687.
    PubMed    
    Abstract available

  174. KABIR SF, Ashik-Ur-Rahman M, Rahman A, Hossen MA, et al
    Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.
    Obstet Gynecol Int. 2025;2025:4476955.
    PubMed    
    Abstract available

  175. ROMANOVA M, Klat J
    Prognostic significance of L1CAM in cervical cancer: A narrative review.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2026.
    PubMed    
    Abstract available

  176. SOLTAU CP, Sinha D, Patil LP, Moseley PM, et al
    Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.
    Redox Biol. 2025;89:103989.
    PubMed    
    Abstract available

  177. YUAN K, Bai Y, Chen S, Shi Y, et al
    The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis.
    Medicine (Baltimore). 2026;105:e46783.
    PubMed    
    Abstract available

  178. ZHAI J, Pang T, An Y, Wang J, et al
    Clinical significance of CXCL17 in cervical cancer.
    Medicine (Baltimore). 2026;105:e46178.
    PubMed    
    Abstract available

  179. HERNANDEZ A, Burrowes S, Gelaw B, Abede T, et al
    Is there a difference in sample adequacy when vaginal HPV DNA samples are self-collected at home, a health post, or a primary care health center in rural Ethiopia? Implications for community cervical cancer screening.
    BMC Womens Health. 2026 Jan 7. doi: 10.1186/s12905-025-04226.
    PubMed    
    Abstract available

  180. ALHMEID EK, Aldohni AAA, Alghanim AI, Salha RM, et al
    Sociodemographic Determinants of Cervical Cancer Screening among Ever-Married Women in Jordan: Insights from the 2023 Jordan Population and Family Health Survey.
    J Epidemiol Glob Health. 2026;16:5.
    PubMed    
    Abstract available

  181. LIU R, Liang L, Wang J, Wang M, et al
    Optimization of Liquid-Based Cytology Block Preparation Using Modified Adhesive Centrifugal Sedimentation for Improved Diagnostic Accuracy in Cervical Lesions.
    APMIS. 2026;134:e70131.
    PubMed    
    Abstract available

  182. NANDAKUMAR V, Krishnan S, Chang CP, Yee S, et al
    High-risk human papillomavirus genotype prevalence in Singapore cervical samples: Implications for clinical management.
    Ann Acad Med Singap. 2025;54:758-765.
    PubMed    
    Abstract available

  183. SURMAVA S, Kvaratskhelia E, Davitashvili B, Vardiashvili N, et al
    Exploratory Analysis of Candidate Gene SNPs in Relation to Cervical Cancer Susceptibility in Georgian Women.
    Cancer Control. 2026;33:10732748251413338.
    PubMed    
    Abstract available

  184. MA LL, Yang SJ
    [Mucosal melanoma with atypical EWSR1 break-apart signal arising in the cervix and vagina: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:93-95.
    PubMed    


  185. CHRISTINE B, Bush M, Thurakal A, Sheehy AM, et al
    New Cervical Cancer Screening Guidelines From the US Department of Health and Human Services: Strengthening Women's Preventive Health.
    JAMA. 2026 Jan 5. doi: 10.1001/jama.2025.26456.
    PubMed    


  186. PENG D, Zhang A, Zhang Y
    Bridging digital divides: A quantitative assessment of equity, access, and determinants of AI adoption for women's reproductive cancer care in China.
    Afr J Reprod Health. 2025;29.
    PubMed    
    Abstract available

  187. YUAN H, Wang X, Liu K, Zhang J, et al
    Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer.
    Int J Womens Health. 2025;17:5719-5731.
    PubMed    
    Abstract available

  188. QIAN XF, Wang XW, Yi HQ, Li LF, et al
    Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.
    Am J Case Rep. 2026;27:e949701.
    PubMed    
    Abstract available

  189. GONG Y, Wu J, Hu Y
    m(6)A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-beta/SMAD signaling in cervical cancer.
    Cancer Gene Ther. 2026 Jan 3. doi: 10.1038/s41417-025-00993.
    PubMed    
    Abstract available

  190. LIU X, Guo L, Zhang H, Xue L, et al
    Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer.
    Int Immunopharmacol. 2026;171:116128.
    PubMed    
    Abstract available

  191. SABEENA S, Beynon C
    The Impact of the COVID-19 Pandemic on HPV Vaccination Coverage Among Adolescents From High-Income Countries and Challenges: A Scoping Review.
    Rev Med Virol. 2026;36:e70102.
    PubMed    
    Abstract available

  192. WU Y, Wei B, Wei Z, Wang H, et al
    Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.
    Commun Biol. 2025;9:46.
    PubMed    
    Abstract available

  193. CHATTERJEE R
    Sexual assault and cancer pathways: a scoping review of biomedical and screening outcomes.
    BMC Womens Health. 2025;26:16.
    PubMed    
    Abstract available

  194. ABUDUREXITI G, Muhetaer K, Yang J, Zhuo Q, et al
    HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023.
    BMC Public Health. 2025;26:102.
    PubMed    
    Abstract available

  195. CALFA S, de Freitas AJA, Causin RL, Hirai W, et al
    Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions.
    Sci Rep. 2025;16:828.
    PubMed    
    Abstract available

  196. GETIE B, Wondimu E, Almaw A, Legese B, et al
    Prevalence and risk factors of high-risk cervical HPV infections among women attending Debre Tabor hospital family planning and gynecology clinic, Northcentral Ethiopia.
    Sci Rep. 2025;16:779.
    PubMed    
    Abstract available

  197. LAM MCY, Mbogo BW, Plaunt E, Mukankaka S, et al
    Transport stipend to facilitate cancer early detection: experiences of beneficiaries and perspectives of program personnel in Rwanda.
    BMC Public Health. 2025;26:13.
    PubMed    
    Abstract available

  198. ALIZADEH L, Keshavarz Z, Shalbaf A, Iranpour S, et al
    Iranian women's perceptions of human papillomavirus and barriers to vaccination: a qualitative study based on the health belief model.
    BMC Public Health. 2025;26:5.
    PubMed    
    Abstract available

  199. LIU Y, Han Z, Kaminski P, Tao C, et al
    Topoisomerase IIalpha orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication.
    Virol Sin. 2025;40:946-961.
    PubMed    
    Abstract available

  200. KHASTGIR G, Saha PK, Bagga R
    From hesitancy to hope: charting India's path to widespread HPV immunisation.
    Eur J Contracept Reprod Health Care. 2026;31:53-58.
    PubMed    
    Abstract available

  201. BROSHKEVITCH CJ, Pretsch PK, Spees LP, Wheeler SB, et al
    Underscreened Women's Reactions to At-Home Self-Collected Human Papillomavirus Test Result Delivery.
    Sex Transm Dis. 2026;53:109-115.
    PubMed    
    Abstract available

  202. KOBAYASHI M, Nakagawa S, Ishii Y, Kamei Y, et al
    VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.
    Cancer Sci. 2026;117:78-89.
    PubMed    
    Abstract available

  203. EBNER C, Purtscheller R, Feroz B, Rieker J, et al
    Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.
    Acta Obstet Gynecol Scand. 2025 Dec 21. doi: 10.1111/aogs.70106.
    PubMed    
    Abstract available

  204. KNUDSEN AS, Randrup TH, Kesmodel US, Booth BB, et al
    Negative margins and negative HPV tests after large loop excision of the transformation zone: A nationwide historical cohort study.
    Acta Obstet Gynecol Scand. 2026;105:186-194.
    PubMed    
    Abstract available

  205. WANG M, Fan J, Mu B, Zeng Y, et al
    HDAC5 stabilization by tubeimoside I suppresses cervical cancer metastasis via inhibiting H3K27ac/KPNA2 axis.
    Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03328.
    PubMed    
    Abstract available

  206. TERZIOGLU HG, Aragao A, Barroeta JE
    "Atypical Glandular Cells" on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow-Up.
    Diagn Cytopathol. 2026;54:71-77.
    PubMed    
    Abstract available

  207. TANG W, Wang L, Li X, Yan X, et al
    Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.
    Gynecol Oncol. 2026;205:17-26.
    PubMed    
    Abstract available

  208. PALMER TJ, Kavanagh K, Cuschieri K, Cameron RL, et al
    Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening.
    Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70183.
    PubMed    
    Abstract available

  209. KALJOUW S, Jansen EEL, Olthof EMG, Hontelez JAC, et al
    Under which realistic circumstances is hrHPV self-sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study.
    Int J Cancer. 2026;158:1361-1369.
    PubMed    
    Abstract available

  210. IMARENGIAYE EO, Iweka RO, Anya CJ, Nwaogwugwu JC, et al
    Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study.
    Int J Gynaecol Obstet. 2026;172:373-382.
    PubMed    
    Abstract available

  211. PERALTA J, Rodriguez J, Acosta JA, Nunez M, et al
    Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70371.
    PubMed    
    Abstract available

  212. KARATAS E, Salman MC, Basaran D, Akgor U, et al
    Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
    PubMed    
    Abstract available

  213. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    PubMed    
    Abstract available

  214. MATSUO K, Matsuzaki S, Roman LD
    Response to "Correspondence on 'Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer' by Matsuo et al" by Hu Y and Fang Q.
    Int J Gynecol Cancer. 2025 Dec 5:102840. doi: 10.1016/j.ijgc.2025.102840.
    PubMed    


  215. XU Q, Han J
    Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2025 Dec 5:102846. doi: 10.1016/j.ijgc.2025.102846.
    PubMed    


  216. SONG Y, Ran G, Zeng R, Chen C, et al
    Global burden and temporal trends of cervical cancer in women aged 60 years and older, 1990-2021: a Global Burden of Disease study.
    Int J Gynecol Cancer. 2025;36:102851.
    PubMed    
    Abstract available

  217. HU Y, Fang Q
    Correspondence on "Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
    Int J Gynecol Cancer. 2025 Nov 26:102831. doi: 10.1016/j.ijgc.2025.102831.
    PubMed    


  218. WANG K, Zhai Q, Xie Y, Tian Y, et al
    Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer.
    Int J Gynecol Cancer. 2025;36:102881.
    PubMed    
    Abstract available

  219. CIANCIA M, Mascilini F, Moro F, Testa AC, et al
    Response to the Correspondence by Xu et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2025 Dec 18:102882. doi: 10.1016/j.ijgc.2025.102882.
    PubMed    


  220. WU Q, Qiu X, Peng R
    Correspondence on "Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study" by Xiao Shang et al.
    Int J Gynecol Cancer. 2025 Dec 16:102873. doi: 10.1016/j.ijgc.2025.102873.
    PubMed    


  221. CIBULA D, Mburu A, Planchamp F, Zapardiel I, et al
    European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer.
    Int J Gynecol Cancer. 2026;36:102747.
    PubMed    
    Abstract available

  222. LEE SS, Banson K, Koduru H, Berger AA, et al
    Factors associated with treatment delay for cervical cancer patients treated with definitive chemoradiation and brachytherapy.
    Int J Gynecol Cancer. 2026;36:102774.
    PubMed    
    Abstract available

  223. TORIGOE R, Dennen C, Mayadev J, Makale MT, et al
    Current challenges in the assessment and management of radiotherapy-induced vaginal stenosis.
    Int J Gynecol Cancer. 2026;36:102801.
    PubMed    
    Abstract available

  224. MARUCCI DA SILVA GF, Pilger TL, Candido Dos Reis FJ
    Incidence of urologic co-morbidities after abdominal radical hysterectomy: a systematic review of clinical trials.
    Int J Gynecol Cancer. 2026;36:102722.
    PubMed    
    Abstract available

  225. WILLIAMS G, Bindra A, Fink D, Weintraub MR, et al
    Survival in human papillomavirus and non-human papillomavirus-associated invasive endocervical adenocarcinoma: outcomes in a large, integrated healthcare system.
    Int J Gynecol Cancer. 2026;36:102683.
    PubMed    
    Abstract available

  226. GAN S, Tang J, Qin S, Ou Q, et al
    Recombinant Listeria expressing the HPV multivalent E6E7 protein has a broader spectrum of anti-tumor effects against cervical cancer.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15476.
    PubMed    
    Abstract available

  227. HAN X, Di R, Zhang H, Zhou B, et al
    Evaluation indicators for bladder dysfunction in Chinese patients following cervical cancer surgery: a Delphi study based on nursing outcomes classification.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15344.
    PubMed    
    Abstract available

  228. KANG Y, Chang L, Lin H, Liu J, et al
    Development and external validation of a machine learning-based prognostic model for small cell neuroendocrine cervical carcinoma: a multi-center study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15338.
    PubMed    
    Abstract available

  229. QIU L, Xie Y, Li Y, Huang J, et al
    Association between serum gamma-Glutamyltransferase and the risk of cervical cancer: Evidence from the national health and nutrition examination survey.
    PLoS One. 2026;21:e0339001.
    PubMed    
    Abstract available

  230. HU J, Wang Y, Liu Y, Cai Z, et al
    Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034.
    PLoS One. 2026;21:e0339923.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;